Pamela Zapata, NP
Nurse Practitioner · Richmond, VANPI 1285357079
Payments from drug & device makers
Across 52 payments — averaging $35.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$981
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$342
- Merz North America, Inc.$136
- SK Life Science, Inc.$124
- Averitas Pharma Inc.$116
- Biogen$84
- plus $87 from 3 others
What the payments were for
- Food & beverage$1,871100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $981 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $342 |
| Merz North America, Inc. | 1 | $136 |
| SK Life Science, Inc. | 1 | $124 |
| Averitas Pharma Inc. | 4 | $116 |
| Biogen | 1 | $84 |
| Vertex | 3 | $55 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$439
- XCOPRI$124
How this compares
$1,871 in reported general payments places this provider in the 85th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 39 | $25,786 |
| Buprenorphine | 59 | $16,300 |
| Gabapentin | 478 | $16,030 |
| Xtampza ErOxycodone Myristate | 11 | $13,405 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 521 | $12,601 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 232 | $9,041 |
| Pregabalin | 136 | $6,693 |
| Lidocaine | 31 | $4,680 |
| Tramadol Hcl | 310 | $3,305 |
| Oxycodone Hcl | 153 | $3,247 |
| Morphine Sulfate ErMorphine Sulfate | 128 | $3,088 |
| Naloxone Hcl | 52 | $2,907 |
| Cyclobenzaprine Hcl | 125 | $2,280 |
| Duloxetine Hcl | 80 | $1,920 |
| Fentanyl | 16 | $1,762 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Richmond
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Angelica KubeRichmond$10K
- Kristin CrainRichmond$8K
- Kristin SeiglerRichmond$7K
- Michele CanfieldRichmond$6K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.